Holly Hagan

Holly Hagan

Holly Hagan

Scroll

Professor Emeritus

Professional overview

Dr. Holly Hagan is Professor Emeritus at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders.  Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.

Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY. 

Education

PhD Epidemiology, University of Washington, Seattle, WA
MPH Epidemiology, University of Massachusetts, Amherst, MA
BA Russian Studies, Evergreen State College, Olympia, WA

Publications

Estimating HIV incidence and the correlates of recent infection in venue-sampled men who have sex with men in New York city

Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment

Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs

Racial/ethnic disparities in HIV infection among people who inject drugs : An international systematic review and meta-analysis

Recommendations for the identification of chronic hepatitis C virus infection among persons born 1945-1965

Reply to high-quality meta-analyses are required for development of evidence in medicine

Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics : Patterns in the international data

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010 : A systematic analysis for the Global Burden of Disease Study 2010

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

Agent, host, and environment : Hepatitis C virus in people who inject drugs

Associations between herpes simplex virus type 2 and HCV with HIV among injecting drug users in New York City : The current importance of sexual transmission of HIV

Can intranasal drug use reduce HCV infection among injecting drug users?

Continuing HIV risk in New York city injection drug users : The association of syringe source and syringe sharing

Current and emerging research needs in studying the NYC HIV-drug Use epidemic

Estimated HIV incidence among high-risk heterosexuals in New York city, 2007

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs : Results of systematic reviews

Introduction : The New York HIV-drug use epidemic: lessons learned and unresolved issues.

Patterns of exchange sex and HIV infection in high-risk heterosexual men and women

Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial

Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention

Recruitment-adjusted estimates of HIV prevalence and risk among men who have sex with men : Effects of weighting venue-based sampling data

Sexual and injection-related risks in Puerto Rican-born injection drug users living in New York City : A mixed-methods analysis

Sexual risk and HIV infection among drug users in New York city : A pilot study

Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women.

Contact

hh50@nyu.edu New York, NY
NYU School of Global Public Health
708 Broadway
New York, NY 10003

Donate to GPH

Make a gift to the GPH Annual Fund

New York University

Equal Opportunity and Non-Discrimination at NYU - New York University is committed to maintaining an environment that encourages and fosters respect for individual values and appropriate conduct among all persons. In all University spaces—physical and digital—programming, activities, and events are carried out in accordance with applicable law as well as University policy, which includes but is not limited to its Non-Discrimination and Anti-Harassment Policy. Unless otherwise noted, all content copyright New York University. All Rights Reserved.